EUVIMEDEUVIMED entdecken
Crossref

A Novel Gene Expression Profile and Combined Effects in the Pathogenesis of Adrenocorticotropic Hormone-Secreting Pituitary Neuroendocrine Tumors

Sera Kayacan, Nurperi Gazioglu, Ceren Orhan, Nil Comunoglu, Pinar Kadioglu, Necmettin Tanriover, Omer Uysal, Fatma Kaya Dagistanli, Melek Ozturk

Experimental and Clinical Endocrinology & Diabetes · 01.07.2025 · 133 (07) · 371-381

DOI: 10.1055/a-2633-8467 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental and Clinical Endocrinology & Diabetes, erschienen am 01.07.2025. Verfasst von Sera Kayacan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Medical Biology, Istanbul University-Cerrahpasa, Istanbul, Turkey. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, ACTH-Secreting Pituitary Adenoma, Pituitary Neoplasms, Transcriptome. Die Arbeit nennt 53 Literaturangaben. Gefördert von: Istanbul Üniversitesi-Cerrahpasa.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cushing’s disease is a rare endocrine disorder characterized by excessive endogenous glucocorticoid production, primarily resulting from adrenocorticotropic hormone-secreting pituitary neuroendocrine tumors (ACTH-PitNETs). This study investigated the expression of several genes implicated in the development of ACTH-PitNETs, including EGFR, USP8, CABLES1, USP2, STAM2, VPS28, HDAC2, IL-6, SMARCA4, WEE1, CDKN2A, CCND1, NR4A1, NEUROD1, and RIPK1. The methylation levels of the USP8 and CDKN2A genes were also assessed for insights into their regulatory mechanisms. Formalin-fixed paraffin-embedded pituitary tumor tissue samples from 32 patients diagnosed with ACTH-PitNET and 15 anterior pituitary tissue samples were analyzed. Gene expression was analyzed through quantitative reverse transcription polymerase chain reaction, while methylation was examined through methylation-specific polymerase chain reaction. All data were analyzed with IBM SPSS Statistics 21. The relationships among gene expressions were assessed using principal component analysis. The expression of CABLES1, NR4A1, CCND1, NEUROD1, USP2, and WEE1 differed significantly between the patient and control groups. Additionally, significant correlations were observed between the levels of RIPK1, SMARCA4, and USP2 and pre-operative cortisol levels; WEE1 expression and pre-operative ACTH levels; CDKN2A expression and urinary cortisol levels; CABLES1, NEUROD1, SMARCA4, and STAM2 expression and post-operative cortisol levels at 48 h. CCND1 expression was correlated with adenoma size, while WEE1 expression was linked to remission status. Notably, the CDKN2A gene displayed partial methylation, whereas the USP8 gene was fully unmethylated. The altered expression levels of the USP2, CABLES1, CDKN2A, and WEE1 may be closely associated with the development of ACTH-PitNETs. Notably, WEE1 emerged as a target gene for predicting clinical remission in patients with Cushing’s disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroendocrine TumorsACTH-Secreting Pituitary AdenomaPituitary NeoplasmsTranscriptomePituitary ACTH HypersecretionHumansFemaleMaleAdultMiddle AgedDNA MethylationAgedGene Expression Regulation, Neoplastic

Autor:innen und Institutionen

  • Medical Biology, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Cerrahpasa Pituitary Center, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Pathology, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Internal Medicine, Endocrinology and Metabolism, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Neurosurgery, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Medical Biostatistics, Istanbul University-Cerrahpasa, Istanbul, Turkey.

Förderung

  • Istanbul Üniversitesi-Cerrahpasa

Zitieren

APA

Kayacan, S., Gazioglu, N., Orhan, C., Comunoglu, N., Kadioglu, P., Tanriover, N., Uysal, O., Kaya Dagistanli, F., & Ozturk, M. (2025). A Novel Gene Expression Profile and Combined Effects in the Pathogenesis of Adrenocorticotropic Hormone-Secreting Pituitary Neuroendocrine Tumors. Experimental and Clinical Endocrinology & Diabetes, 133(07), 371-381. https://doi.org/10.1055/a-2633-8467

Vancouver

Kayacan S, Gazioglu N, Orhan C, Comunoglu N, Kadioglu P, Tanriover N, et al. A Novel Gene Expression Profile and Combined Effects in the Pathogenesis of Adrenocorticotropic Hormone-Secreting Pituitary Neuroendocrine Tumors. Experimental and Clinical Endocrinology & Diabetes. 2025;133(07):371-381. doi:10.1055/a-2633-8467

BibTeX
@article{Kayacan2025,
  author = {Kayacan, Sera and Gazioglu, Nurperi and Orhan, Ceren and Comunoglu, Nil and Kadioglu, Pinar and Tanriover, Necmettin and Uysal, Omer and Kaya Dagistanli, Fatma and Ozturk, Melek},
  title = {A Novel Gene Expression Profile and Combined Effects in the Pathogenesis of Adrenocorticotropic Hormone-Secreting Pituitary Neuroendocrine Tumors},
  journal = {Experimental and Clinical Endocrinology & Diabetes},
  year = {2025},
  volume = {133},
  number = {07},
  pages = {371--381},
  doi = {10.1055/a-2633-8467}
}
Kostenlos starten →